Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes

Published:2021-05-24 Issue:2 Volume:107 Page:219-228
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Larfors Gunnar¹^ORCID,Moreno Berggren Daniel¹,Garelius Hege²,Jädersten Martin³,Nilsson Lars⁴,Rasmussen Bengt⁵,Ejerblad Elisabeth¹

Affiliation:

1. Unit of Haematology Department of Medical Sciences Uppsala University Uppsala Sweden

2. Section of Haematology and Coagulation Department of Specialist Medicine Sahlgrenska University Hospital Gothenburg Sweden

3. Department of Medicine Huddinge Centre for Haematology and Regenerative Medicine Karolinska Institutet Karolinska University Hospital Stockholm Sweden

4. Department of Haematology, Oncology and Radiation Physics Skåne University Hospital Lund Sweden

5. School of Medical Sciences Örebro University Hospital Örebro Sweden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13641

Reference41 articles.

1. Myelodysplastic Syndromes

2. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

3. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries

4. Myelodysplastic syndrome in New Zealand and Australia

5. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling sex-based geographical disparities in myelodysplastic syndrome mortality trends in Spain (1999–2022);Clinical and Translational Oncology;2024-05-19

2. 10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark;Leukemia Research;2023-05

3. The Circular RNA Circ-ANAPC7 as a Biomarker for the Risk Stratification of Myelodysplastic Syndrome;Indian Journal of Hematology and Blood Transfusion;2022-11-18

4. Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study;Hematological Oncology;2022-09-06